Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Minerva Surgical stock (UTRS)

Buy Minerva Surgical stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Minerva Surgical is a medical devices business based in the US. Minerva Surgical shares (UTRS) are listed on the PINK and all prices are listed in US Dollars. Minerva Surgical employs 174 staff and has a trailing 12-month revenue of around $51.7 million.

Our top picks for where to buy Minerva Surgical stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Minerva Surgical stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – UTRS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Minerva Surgical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Minerva Surgical stock price (PINK: UTRS)

Use our graph to track the performance of UTRS stocks over time.

Minerva Surgical shares at a glance

Information last updated 2024-07-19.
Latest market close$0.01
52-week range$0.00 - $6.16
50-day moving average $0.01
200-day moving average $0.95
Wall St. target price$3.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-7.61

Minerva Surgical price performance over time

Historical closes compared with the close of $0.012 from 2024-07-23

1 week (2024-07-17) 0.012
1 month (2024-06-24) 9.09%
3 months (2024-04-24) -97.07%
6 months (2024-01-24) -98.75%
1 year (2023-07-24) -95.38%
2 years (2022-07-22) -99.52%
3 years (2021-07-20) N/A
5 years (2019-07-20) N/A

Minerva Surgical financials

Revenue TTM $51.7 million
Gross profit TTM $27.2 million
Return on assets TTM -27.35%
Return on equity TTM -160.08%
Profit margin -64.71%
Book value $2.28
Market Capitalization $13.1 million

TTM: trailing 12 months

Minerva Surgical share dividends

We're not expecting Minerva Surgical to pay a dividend over the next 12 months.

You may also wish to consider:

Have Minerva Surgical's shares ever split?

Minerva Surgical's shares were split on a 1:20 basis on 1 October 2023. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Minerva Surgical shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Minerva Surgical shares which in turn could have impacted Minerva Surgical's share price.

Minerva Surgical share price volatility

Over the last 12 months, Minerva Surgical's shares have ranged in value from as little as $0.001 up to $6.16. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Minerva Surgical's is 4.856. This would suggest that Minerva Surgical's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put Minerva Surgical's beta into context you can compare it against those of similar companies.

Minerva Surgical overview

Minerva Surgical, Inc. , a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. .

Frequently asked questions

What percentage of Minerva Surgical is owned by insiders or institutions?
Currently 0.425% of Minerva Surgical shares are held by insiders and 70.084% by institutions.
How many people work for Minerva Surgical?
Latest data suggests 174 work at Minerva Surgical.
When does the fiscal year end for Minerva Surgical?
Minerva Surgical's fiscal year ends in December.
Where is Minerva Surgical based?
Minerva Surgical's address is: 4255 Burton Drive, Santa Clara, CA, United States, 95054
What is Minerva Surgical's ISIN number?
Minerva Surgical's international securities identification number is: US60343F1066

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site